Biote Medical Announces Appointments Board of Directors

Sept. 21, 2021 12:00 UTC


Dr. Mark Cone and Dana L. Jacoby elected to the Board of Directors for Biote Medical


IRVING, Texas--(BUSINESS WIRE)-- BioTE Medical, a hormone optimization company that provides evidence-based therapeutic solutions to treat hormone imbalances in women and men, today announced the appointments of Dr. Mark Cone and Dana Jacoby to the company’s Board of Directors. Cone and Jacoby bring six decades of combined experience in healthcare practice and business leadership to the company’s Board.

This press release features multimedia. View the full release here:

Dana Jacoby (Photo: Business Wire)

Dana Jacoby (Photo: Business Wire)

“The appointments of Dr. Cone and Dana Jacoby will support Biote’s continued growth as we scale our commercial efforts to support rapid national expansion to address the over 200 million Americans suffering with hormone deficiency,” said Terry Weber, Chief Executive Officer of Biote Medical. “Biote is transforming healthy aging with precision hormone therapy optimized by a proprietary dosing algorithm. These additions to our board will provide valuable contributions to our mission, science and commercial success.”

Dr. Mark Cone brings 30 years of healthcare leadership and women’s health expertise and advocacy to Biote Medical’s Board. He is the Market President of Privia Health’s South Texas market (Nasdaq: PRVA), a national physician practice management company. He is the President of Privia Medical Group Gulf Coast, a 300-provider multi-specialty group. Cone is Vice President of the Board of Directors of the U.S. Women’s Health Alliance and Chairman of the Board of Global Women’s Health Providers, a Cedar Gate Technologies company. Prior to this Cone was the CEO of Complete MD Solutions, a physician management company, where he developed and implemented a corporate structure that maximizes practices’ autonomy and profitability. He holds a Doctor of Medicine from Baylor College of Medicine and a Bachelor of Science in biology and medicine from Texas A&M University. He currently practices Gynecology in Houston, Tx.

Dana Jacoby joins Biote Medical’s Board with more than 20 years of experience in a wide range of medical specialties, including urology, urogynecology, gastroenterology, dermatology, orthopedics, and oncology. She is Chief Executive Officer of Vector Medical Group, LLC and has consulted healthcare clients through nearly $1 billion in mergers, transactions and acquisitions. Jacoby has also held leadership roles at Specialty Networks Consulting, BSM Consulting, GE Healthcare, Allergan, and Johnson and Johnson. She holds a Master of Health Systems from the University of Medicine and Dentistry of New Jersey, a Master of Business Administration from the Wharton Fellows Program, a Master of Management from Tulane University, and a Bachelor of Science in political science and public relations from Louisiana State University.

About Biote Medical
Biote Medical is a hormone optimization company that has translated decades of scientific insight into clinically-validated medical approaches that identify and treat imbalances in the production of hormones. By partnering with medical providers across the United States, Biote Medical is educating practitioners on the scientific evidence of the roles of hormones and supplements to support improved health. We are dedicated to helping patients live better, longer by changing the way healthcare is practiced on a global level.


Chelsea-Lyn Rudder

Mike Cavanaugh


Source: Biote Medical

Smart Multimedia Gallery

Dana Jacoby (Photo: Business Wire)

Dr. Mark Cone (Photo: Business Wire)

View this news release and multimedia online at:

Back to news